On-demand KVD900 Speeds Symptom Relief, Reduces Use of Rescue Medicines

On-demand KVD900 Speeds Symptom Relief, Reduces Use of Rescue Medicines

286256

On-demand KVD900 Speeds Symptom Relief, Reduces Use of Rescue Medicines

Using oral KVD900 as an on-demand treatment for hereditary angioedema (HAE) attacks is safe and significantly reduces both the use of rescue medications and the time to symptom relief, according to top-line results of a recently completed Phase 2 trial. Notably, the oral therapy significantly speeded up the time it took to ease patients’ symptoms — to less than two hours, as compared with about nine hours. Such results are similar to those now achieved…

You must be logged in to read/download the full post.